Asepsis Medical Technologies® is proud to introduce the latest addition to the Calibrated Drug Delivery™ (CCD) platform, the Multi-Dose Safe-2-Dose®...Read More
Asepsis Medical Technologies announces the U.S. Patent Grant for the Momenta-Dose™ forcé actuated injection device. The Momenta Dose™ is designed to administer...Read More
Asepsis announces the patent pending Safe-2-Dose™, the next generation liquid medication dispenser. The caregiver need only unlock the device and...Read More
Asepsis Announces Australian Patent Acceptance No. 2018232988 for its Multi-Indicia Infants’ and Children’s Oral Medication Dosing Applicator Comprising a Medication Paired Keyed End.
Asepsis Medical Technologies announces the Australian Patent Acceptance No. 2018232988 for a suction and/or pressure inducing oral medication dosing applicator. The applicator...Read More
Asepsis announces the USPTO Notice of Allowance for its second Patent Application for the Safe-T-Fuse™ specialty drug infusion system.
Asepsis Medical Technologies announces the USPTO issuance of Patent Application Number 15/255,725 for its Safe-T-Fuse™ drug infusion system. The Safe-T-Fuse™ is an...Read More
Asepsis announces the USPTO Notice of Allowance for Patent Application No. 14/877,349 encompassing the prefilled and ready to fill, Diluent-2-Dose™ syringe.
Read More… U.S. Patented Application 14/877,349 and Diluent-2-Dose™Read More